Fecal microbiota transplantation (FMT) is a highly effective treatment for recurrent Clostridioides difficile infections, which affect 500,000 Americans annually and result in 30,000 deaths. Despite its efficacy, access to FMT remains limited, particularly for children, due to the scarcity of pediatric-specific stool samples. Dr. Nikhil Pai, a pediatric gastroenterologist in Canada, is addressing this gap by establishing the country’s first pediatric stool bank, which has stored over 150 samples and completed five FMT procedures since 2022. His team is also pioneering oral “crapsules” to simplify treatment delivery. But could these advancements unlock the potential of FMT for other diseases beyond C. difficile?
Keep Reading
Add A Comment